Системные гипертензии (Mar 2009)

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial

  • - Giuseppe Derosa,
  • - Arrigo FG Cicero,
  • - Angela D'Angelo,
  • - Elena Fogari,
  • - Sibilla Salvadeo,
  • - Alessia Gravina,
  • - Ilaria Ferrari,
  • - Raffaella Fassi,
  • - Roberto Fogari

Journal volume & issue
Vol. 6, no. 1
pp. 54 – 58

Abstract

Read online

No abstracts available.

Keywords